ARTIFICIAL INTELLIGENCE IN EARLY ONCOLOGY SCREENING: A SYSTEMATIC REVIEW OF ETHICAL IMPLICATIONS, HEALTH EQUITY, AND DIGITAL ACCESS DISPARITIES

Karolina Magda Leszczyńska; Anna Krzysztofik; Kamila Teresa Kańska; Karolina Julia Hak; Jeremi Leon Jasiński; Alicja Maria Mitan; Karolina Krawczyk; Maciej Tomasz Wieczorek; Weronika Napierała; Aleksandra Maria Tomaszewska

doi:10.31435/ijitss.1(49).2026.5187

Authors

Karolina Magda Leszczyńska Pomeranian Medical University, Szczecin, Poland https://orcid.org/0009-0000-6427-7269
Anna Krzysztofik Pomeranian Medical University, Szczecin, Poland https://orcid.org/0009-0002-3130-1917
Kamila Teresa Kańska Pomeranian Medical University, Szczecin, Poland https://orcid.org/0009-0005-2702-7013
Karolina Julia Hak Independent Public Provincial Integrated Hospital in Szczecin, Szczecin, Poland https://orcid.org/0009-0009-7641-0237
Jeremi Leon Jasiński Pomeranian Medical University, Szczecin, Poland https://orcid.org/0009-0004-1690-5936
Alicja Maria Mitan Fryderyk Chopin University Clinical Hospital in Rzeszów, Rzeszów, Poland https://orcid.org/0009-0004-5617-5034
Karolina Krawczyk Pomeranian Medical University, Szczecin, Poland https://orcid.org/0009-0005-1191-5788
Maciej Tomasz Wieczorek Pomeranian Medical University, Szczecin, Poland https://orcid.org/0009-0007-4058-7650
Weronika Napierała Jerzy Popiełuszko Hospital of Bielany, Warsaw, Poland https://orcid.org/0009-0005-1411-4046
Aleksandra Maria Tomaszewska University Clinical Hospital of Bialystok, Białystok, Poland https://orcid.org/0009-0000-4684-0492

DOI:

https://doi.org/10.31435/ijitss.1(49).2026.5187

Keywords:

Artificial Intelligence, Oncology Screening, Health Equity, Digital Divide, Ethical Governance, Social Determinants of Health

Abstract

Background: Artificial intelligence (AI) has rapidly evolved in oncology over the past decade, transforming early cancer screening through advances in imaging analytics, predictive modeling, and data-driven risk stratification [6,9,17]. Early research primarily focused on diagnostic performance and technical efficiency, however, recent literature increasingly emphasizes the ethical, social, and structural consequences of AI integration into healthcare systems [2,6,8].

Objective: This review analyzes the development of AI in early oncology screening between 2018 and 2026, focusing on ethical implications, health equity, and digital access disparities at the intersection of technology and society.

Methodology: A structured literature review was conducted using the PubMed database. Peer-reviewed review articles and policy-oriented studies published between 2018 and 2026 were analyzed. Inclusion criteria comprised relevance to AI-based cancer screening, ethical governance, health equity, social determinants of health, and digital inclusion [1–10].

Results: The literature demonstrates a shift from performance-centered AI development toward socially informed frameworks emphasizing fairness, transparency, and governance [1,6,8]. Although AI technologies enhance early detection potential [9,17], consistent evidence highlights risks of algorithmic bias, unequal access to digital infrastructure, and reinforcement of pre-existing health disparities [2,5,10,12,15]. Vulnerabilities are particularly evident among socioeconomically disadvantaged populations and in low- and middle-income countries (LMICs), where infrastructural limitations restrict equitable implementation [2,18].

Conclusion: AI in early oncology screening holds substantial clinical promise, however, without ethically grounded governance and equity-oriented policy frameworks, its deployment risks amplifying structural inequalities. Sustainable integration requires inclusive data practices, digital access equity, and human-centered regulatory models to ensure socially responsible innovation. Technological innovation in oncology cannot be evaluated independently of its social context and systemic determinants.

References

Chen, R. J., Wang, J. J., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Lu, M. Y., et al. (2023). Algorithmic fairness in artificial intelligence for medicine and healthcare. Nature Medicine, 29, 846–857. https://doi.org/10.1038/s41591-023-02274-3

Dankwa-Mullan, I., Ndoh, K., Akogo, D., Rocha, H. A. L., & Juaçaba, S. F. (2024). Artificial intelligence and cancer health equity: Bridging the divide or widening the gap? Cancer Discovery.

Gichoya, J. W., Banerjee, I., Bhimireddy, A. R., Burns, J. L., Celi, L. A., Chen, L. J., et al. (2022). AI recognition of patient race in medical imaging: A modelling study. The Lancet Digital Health, 4, e406–e414.

Glocker, B., Jones, C., Bernhardt, M., & Winzeck, S. (2023). Algorithmic encoding of protected characteristics in chest X-ray disease detection models. EBioMedicine, 89, 104467.

Hooker, S. (2021). Moving beyond “algorithmic bias is a data problem”. Patterns, 2, 100241.

Istasy, P., Lee, W. S., Iansavichene, A., Upshur, R., Gyawali, B., Burkell, J., et al. (2022). The impact of artificial intelligence on health equity in oncology: A scoping review. JCO Global Oncology, 8, e2200209. https://doi.org/10.1200/GO.22.00209

Kelkar, A. H., Hantel, A., Koranteng, E., Cutler, C. S., Hammer, M. J., & Abel, G. A. (2023). Digital health to patient-facing artificial intelligence: Ethical implications and threats to dignity for patients with cancer. JCO Oncology Practice.

Konate, S., Gallifant, J., Senteio, C., Celi, L. A., & Seyyed-Kalantari, L. (2025). Rethinking fairness in AI to improve current practice in oncology. The Lancet Digital Health.

Luchini, C., Pea, A., & Scarpa, A. (2022). Artificial intelligence in oncology: Current applications and future perspectives. British Journal of Cancer, 126, 4–9. https://doi.org/10.1038/s41416-021-01633-1

McCradden, M. D., Joshi, S., Mazwi, M., & Anderson, J. A. (2020). Ethical limitations of algorithmic fairness solutions in health care machine learning. The Lancet Digital Health, 2, e221–e223.

Mehrabi, N., Morstatter, F., Saxena, N., Lerman, K., & Galstyan, A. (2021). A survey on bias and fairness in machine learning. ACM Computing Surveys, 54(6), 1–35.

Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447–453. https://doi.org/10.1126/science.aax2342

Panch, T., Mattie, H., & Celi, L. A. (2019). The “inconvenient truth” about AI in healthcare. NPJ Digital Medicine, 2, 77.

Roadevin, C., & Hill, H. (2025). AI interventions in cancer screening: Balancing equity and cost-effectiveness. The Lancet Digital Health.

Seyyed-Kalantari, L., Zhang, H., McDermott, M., Chen, I. Y., & Ghassemi, M. (2021). Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in underserved patient populations. Nature Medicine, 27, 2176–2182.

Srivastav, A. K., Singh, A., Singh, S., Rivers, B., Lillard, J. W., Jr., & Singh, R. (2025). Revolutionizing oncology through AI: Addressing cancer disparities by improving screening, treatment, and survival outcomes via integration of social determinants of health. Frontiers in Oncology.

Wu, Q., Huang, Y., Wang, S., Qi, L., Zhang, Z., Hou, D., et al. (2024). Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis. Cancer Medicine.

Zhang, Y., Peng, D., & Zhang, A. (2025). Artificial intelligence in cancer diagnostics: Governance for equity in low- and middle-income countries. Frontiers in Oncology.